EIA report of Tianli Pharmaceutical’s Phase II of VC deep-processing project

In late October, the EIA report of the Phase II of vitamin C (VC) deep-processing project of Shandong Tianli Pharmaceutical Co., Ltd. (Tianli Pharmaceutical) was made a public announcement in the company's website.Type: New projectTotal investment: U...

Vitamins China E-News 201911